These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23896707)

  • 21. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Case of primary malignant lymphoma of the bladder].
    Goto D; Otani T; Tomioka A; Maruyama Y
    Hinyokika Kiyo; 2013 Sep; 59(9):583-6. PubMed ID: 24113757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma.
    Hornberger JC; Best JH
    Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
    Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
    Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma.
    Maguire A; Castriciano G; Walker J; Molloy K; Quinn F; Osman N; Vandenberghe E; Jeffers M; Gaffney E; Flavin R
    Int J Gynecol Pathol; 2015 Sep; 34(5):459-64. PubMed ID: 25996637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern.
    Yu G; Gao Z; Huang X
    Int J Clin Exp Pathol; 2014; 7(12):9086-9. PubMed ID: 25674293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.
    Chen J; Feng X; Dong M
    Int J Clin Exp Pathol; 2015; 8(2):2123-30. PubMed ID: 25973114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
    Sehn LH; Connors JM
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma.
    Yu JI; Nam H; Ahn YC; Kim WS; Park K; Kim SJ
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):507-12. PubMed ID: 20056353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A primary malignant lymphoma of the appendix].
    Shimada K; Sato M; Haruyama S; Ichikawa T; Aono G; Ohara T; Ando Y; Abe R; Nozawa Y; Wakasa H
    Gan No Rinsho; 1990 Sep; 36(11):2086-91. PubMed ID: 2232177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcomatoid variant of B-cell lymphoma of the uterine cervix.
    Kahlifa M; Buckstein R; Perez-Ordoñez B
    Int J Gynecol Pathol; 2003 Jul; 22(3):289-93. PubMed ID: 12819398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.
    Shivakumar L; Armitage JO
    Clin Lymphoma Myeloma; 2006 May; 6(6):455-7. PubMed ID: 16796775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains.
    Yahalom J
    J Clin Oncol; 2010 Sep; 28(27):4105-7. PubMed ID: 20713874
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary malignant lymphoma of the adrenal gland: a case report].
    Mizusawa H; Okaneya T; Yoneyama T; Taguchi I
    Hinyokika Kiyo; 1995 Dec; 41(12):991-4. PubMed ID: 8578989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
    Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
    Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.